Prestige Consumer Healthcare Inc. Stock
We can see a decrease in the price for Prestige Consumer Healthcare Inc.. Compared to yesterday it has lost -€0.600 (-1.300%).
Currently there is a rather positive sentiment for Prestige Consumer Healthcare Inc. with 4 Buy predictions and 0 Sell predictions.
With a target price of 61 € there is a positive potential of 34.36% for Prestige Consumer Healthcare Inc. compared to the current price of 45.4 €.
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -1.300% | 7.306% | 14.078% | -16.071% | -12.150% | -21.008% | -6.931% |
| Apollo Medical Holdings, Inc. | 0.000% | -1.282% | -24.510% | 64.706% | 45.283% | -13.483% | -57.222% |
| Petmed Express Inc | -1.760% | 1.238% | -1.661% | -36.171% | -40.506% | -85.134% | -93.151% |
| Suzuken Co Ltd | 0.000% | -4.412% | -0.763% | 4.000% | -20.732% | 4.000% | 6.557% |
Comments
Prestige Consumer Healthcare (PBH) had its price target lowered by Canaccord Genuity Group Inc. from $86.00 to $72.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (PBH) had its price target lowered by Oppenheimer Holdings, Inc. from $77.00 to $65.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat